Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.
about
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisThrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosisQuantification of IGF-1 Receptor May Be Useful in Diagnosing Polycythemia Vera-Suggestion to Be Added to Be One of the Minor CriterionClinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteriaAdvances and challenges in the management of essential thrombocythemia.Myeloproliferative neoplasms: Morphology and clinical practice.Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera.JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms.The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations.Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study.WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes.
P2860
Q26772881-A1835C73-EF2D-4FA1-A5E6-BC00B65E4EDDQ35532006-CBA88742-71A2-49AF-BB06-CCF83F804358Q36182119-BDF1D29F-75B1-44C9-AADA-C35AD35CEEB9Q36874807-D5117EE5-3B8C-4182-842C-CBE997301E90Q38542093-C4305B1B-6E45-409E-8330-0BFEAF4DBF92Q38683559-91850DC3-14A4-4593-BA1A-784D5E93EA6FQ38764516-14610BCD-73EB-4DE3-B329-1715FA0B94A0Q41085322-AD594FB0-BCE2-4A71-997C-5C84FCC20904Q49612978-F5A81E96-E42D-4598-BA42-188F88C67043Q52844230-2EFD41C9-D62B-4DE6-B12E-B4548AEB69A1Q52862082-F7EAB53F-927B-4604-8039-527D3D66F1EFQ53147519-23C45116-EA41-4020-B14A-F1412EB9A555
P2860
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Reproducibility of the WHO his ...... myeloproliferative neoplasms.
@en
Reproducibility of the WHO his ...... myeloproliferative neoplasms.
@nl
type
label
Reproducibility of the WHO his ...... myeloproliferative neoplasms.
@en
Reproducibility of the WHO his ...... myeloproliferative neoplasms.
@nl
prefLabel
Reproducibility of the WHO his ...... myeloproliferative neoplasms.
@en
Reproducibility of the WHO his ...... myeloproliferative neoplasms.
@nl
P2093
P2860
P50
P1433
P1476
Reproducibility of the WHO his ...... myeloproliferative neoplasms.
@en
P2093
Ada M Florena
Alessandra Iurlo
Alessia Moro
Elena Sabattini
Emanuela Bonoldi
Emanuela Boveri
Giulio F Orcioni
Luigi Gugliotta
Maurilio Ponzoni
Riccardo Valli
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.196
P577
2013-11-08T00:00:00Z
P5875
P6179
1045376468